Article

February 29, 2012

Dr. Robert Dubois On Promoting Comparative Results Vs. Methodology

Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council, discusses the different circumstances in the level of restrictions and evidence regarding comparative effectiveness research. In addition, Dr. Dubois asks whether the standards around safety differ from those around efficacy.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

Gordon Crofoot, MD, PA

David Awad, PharmD, BCOP

Merrill H. Stewart, MD

Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center

Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center

Hamlet Gasoyan, PhD

EHA 2025 Congress Recap | Image Credit: Venngage

Coral Omene, MD, PhD, sitting for a vieo interview

Related Content

Mansi Shah, MD

June 11th 2025

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

Laura Joszt, MA Hayden E. Klein Mansi Shah, MD

Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.

June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

Gary Falcetano, PA-C, AE-C.

June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

Gary Falcetano, PA-C, AE-C

May 30th 2025

Chronic Allergic Inflammation's Impact on Brain Chemistry and Mood: Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explained that chronic allergic inflammation can significantly affect brain chemistry and mood regulation.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Related Content

Mansi Shah, MD

June 11th 2025

Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD

Laura Joszt, MA Hayden E. Klein Mansi Shah, MD

Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies.

June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS

Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.

Gary Falcetano, PA-C, AE-C.

June 4th 2025

Proactively Protecting Mental and Physical Health During Peak Allergy Season With Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explains that proactively managing seasonal allergies can significantly decrease the overall inflammatory burden, thereby improving both physical symptoms and potentially mitigating neuroinflammation's impact on mental well-being.

May 29th 2025

Laundromats as a New Frontier in Community Health, Medicaid Outreach

Brooke McCormick Lindsey Jeanne Leininger, PhD Allister Chang, MPA

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

Gary Falcetano, PA-C, AE-C

May 30th 2025

Chronic Allergic Inflammation's Impact on Brain Chemistry and Mood: Gary Falcetano, PA-C, AE-C

Cameron Santoro Gary Falcetano, PA-C, AE-C

Gary Falcetano, PA-C, AE-C, explained that chronic allergic inflammation can significantly affect brain chemistry and mood regulation.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions